ECC 2015: Rare Cancer Activities & Highlights
The SIOPE Session, Tackling Rare Cancers Requiring Specialist Care: ERNs, & Scientific Symposium: Bayesian, Adaptive and Rare Disease Designs
News
New drugs could stop the growth of drug-resistant childhood tumors
Scientists identify a new drug target and demonstrate its effectiveness compared to existing treatments
ESMO E-Learning: Multidisciplinary Treatment for Glioblastoma
Providing an update on key diagnostic, clinical, molecular, prognostic and predictive characteristics in patients with newly diagnosed and recurrent glioblastomarovide an update on key diagnostic, clinical, molecular, prognostic and predictive characteristics in patients with newly diagnosed and recurrent glioblastoma
Updated MAC-NPC meta-analysis: concomitant chemotherapy to radiotherapy improves survival in locoregionally advanced nasopharyngeal carcinoma
Results of the updated Meta-Analysis of Chemotherapy in Nasopharynx Carcinoma (MAC-NPC) collaborative group meta-analysis of individual patient data also including recent clinical trials, published in theLancet Oncology
EMA/ESMO/Rare Cancers Europe: Joint workshop on chordoma as a model for very rare cancers
The aim of this workshop is to discuss scientific and regulatory evidence requirements for rare diseases, main challenges and identify possible methodological solutions that could work for this and other very rare cancers.